European regulatory aspects on new medicines targeted at treatment of rheumatoid arthritis

Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I92-5. doi: 10.1136/ard.58.2008.i92.
No abstract available

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Controlled Clinical Trials as Topic / methods
  • Drug Approval / legislation & jurisprudence
  • Drug Approval / organization & administration*
  • European Union
  • Humans
  • Treatment Outcome

Substances

  • Antirheumatic Agents